Subsidiaries of STANDARD BIOTOOLS INC. as disclosed in its SEC filing
Entity
Jurisdiction
Note
SB Sciences Inc.
Delaware
Standard BioTools Australia Pty. Ltd.
Australia
Standard BioTools (Shanghai) Instrument Technology Company Limited
China
Standard BioTools K.K.
Japan
Standard BioTools Europe B.V.
Netherlands
Standard BioTools Singapore Pte. Ltd.
Singapore
Standard BioTools France SARL
France
Standard BioTools GmbH
Germany
Standard BioTools Italy S.r.l.
Italy
Standard BioTools Spain S.l.
Spain
Financial health
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Piotroski F-score
3 / 8
FAILReturn on assets positiveROA -13.2%
FAILOperating cash flow positiveOCF -74M
PASSReturn on assets improving-22.7% → -13.2%
PASSCash flow exceeds earningsOCF -74M vs NI -75M
FAILLong-term debt ratio fallingno debt reported
FAILCurrent ratio improving5.70 → 4.19
FAILNo share dilution353M → 382M shares
PASSGross margin improving48.3% → 49.9%
FAILAsset turnover improving0.28× → 0.15×
Altman Z-score
-1.77distress
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
Six-year record
Year
Revenue
Net income
Free cash flow
Gross margin
Shares
FY2020
$138.1M
−$53.0M
−$28.1M
—
72,044,000
FY2021
$130.6M
−$59.2M
−$57.3M
—
75,786,000
FY2022
$97.9M
−$190.1M
−$93.2M
37.8%
78,305,000
FY2023
$106.3M
−$74.7M
−$46.1M
47.4%
79,160,000
FY2024
$174.4M
−$138.9M
−$151.8M
48.3%
353,245,000
Ownership flow
12 institutions tracked — 4 added, 6 reduced, 1 opened a new position, 1 sold out. Active managers added 1,856,169 shares while index money cut 21,855,998.
Institutional holders of STANDARD BIOTOOLS INC. and their share-count change
Manager
Kind
Shares
Change
Value
BlackRock, Inc.
Index
8,254,443
−16,501,641
$6.8B
STATE STREET CORP
Index
1,542,478
−5,014,031
$1.3B
CITADEL ADVISORS LLC
Hedge fund
2,376,970
+1,108,460
$2.0B
Point72 Asset Management, L.P.
Hedge fund
707,991
Identity
CIK
0001162194
LEI
549300GX8Y96GSB6YP89
FIGI
BBG000S8WQB6
SIC
2834 · Pharmaceutical Preparations
Incorporated
DE
Headquarters
BOSTON, MA
Founded
1999-00-00
Ownership
Institutional
75.2%
Institutions
171
Insiders
1.8%
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
How many subsidiaries does STANDARD BIOTOOLS INC. file with the SEC?
13, listed in its most recent exhibit 21. They are incorporated across 13 jurisdictions, led by Delaware, Australia, China. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is STANDARD BIOTOOLS INC. financially healthy?
STANDARD BIOTOOLS INC. scores 3 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Its Altman Z-score puts it in the distress zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of STANDARD BIOTOOLS INC.?
Among the managers tracked here, the biggest positions as of the 2026-Q3 13F filings are VIKING GLOBAL INVESTORS LP (unchanged), BlackRock, Inc. (trimming), GEODE CAPITAL MANAGEMENT, LLC (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.
This page is one panel of the terminal
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
Standard BioTools Sweden A.B.
Sweden
Standard BioTools Switzerland GmbH
Switzerland
Standard BioTools UK Limited
United Kingdom
Cash conversion
99.3%
Share count change
8.0%
FY2025
$85.3M
−$74.9M
−$82.6M
49.9%
381,623,000
+663,270
$582.5M
AQR CAPITAL MANAGEMENT LLC
Hedge fund
1,359,018
+425,920
$1.1B
GEODE CAPITAL MANAGEMENT, LLC
Index
3,556,248
−340,326
$2.6B
BANK OF AMERICA CORP /DE/
Active fund
244,084
−176,481
$200.6M
JPMORGAN CHASE & CO
Active fund
7,003
−110,883
$5.2M
MORGAN STANLEY
Active fund
2,831,668
−55,478
$2.3B
FMR LLC
Active fund
4,514
+1,361
$3.3M
RENAISSANCE TECHNOLOGIES LLC holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register. These filings span 2026-Q2–2026-Q3 rather than a single quarter, because filers report on their own schedules.